News

The company leverages 3D bioreactor technology in the production of the PLX cells to tackle issues such as reproducibility, production costs and quality. Pluristem chairman and CEO Zami

The FDA-approved facilities in the US, will manufacture Live Young Naturals product line. Hokutou CEO Eugene Collins said 70% of US adults use dietary supplements, and over $30bn

According to the company, from the €2.6m grant it will receive €215.000, which would be used in its ongoing three year project of determining the clinical value of

As part of the acquisition, the tendered shares were also transferred to BASF. In addition, BASF is setting up a compulsory acquisition process (squeeze out) to acquire the

The firm is planning to sell the shares through its wholly-owned subsidiary Elan Science Three and is expected to close the deal on 6 February 2013. Elan through

The scalability solution has become a major concern with over 10,000 lines to be serialized within the life sciences industry over the next 5 years, according to the

As part of the appraisal, NICE has issued a ‘Minded Not to Recommend’ and requested for the further information and analysis on the submitted cost-effectiveness model. Used as

Lennon will take the responsibility of firm’s global business development plans and work with the European and North American management teams. Lennon joined Clondalkin in 2009 as CEO

The collaboration, which forms part of MagForce’s new vision to conduct early-stage research and development with academic institutions, will form a more efficient magnetic fluid and a pilot